Report Feature
A total of XX figures / charts and XX tables are provided in more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global gene panel market report, please download the report brochure.
In this market, test kits is the largest product and service of gene panel, whereas cancer risk assessment is the fastest growing application. Growth in various segments of the gene panel market are given below:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- Test Kits
- Testing Services
- Amplicon-based Approach
- Hybridization-based Approach
By Design [Value ($ Million) shipment analysis for 2014 – 2025]:
- Predesigned Gene Panel
- Customized Gene Panel
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Cancer Risk Assessment
- Diagnosis of Congenital Diseases
- Pharmacogenetics
- Other Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the gene panel model companies profiled in this report include Thermo Fisher Scientific, Illumina, BGI, Agilent Technologies, Eurofins Scientific, QIAGEN, GENEWIZ, Novogene Corporation, and Personalis.
Lucintel forecasts that test kits will remain the largest product and service segment over the forecast period due to growing demand for gene panel in research as well as diagnostics to understand the genetic variability of chronic disorders.
Within this market, cancer risk assessment will remain the highest growing segment by application over the forecast period due to the increasing incidence of cancer and growing demand for gene panel in research and diagnostics to understand the genetic variability of cancer.
North America will remain the largest region over the forecast period due to growing research on cancer and inherited rare diseases, and government support for genomic research in the region.
|
Features of the Global Gene Panel Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global gene panel market by product & service (test kits and testing services), technique (amplicon-based approach and hybridization-based approach), design (predesigned gene panel and customized gene panel), application (cancer risk assessment, diagnosis of congenital diseases, pharmacogenetics, and other applications), end user (research and academic institutes, hospital and diagnostic laboratories, and pharmaceutical and biotechnology companies), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global gene panel market? Q.5 What are the business risks and threats to the global gene panel market? Q.6 What are the emerging trends in this gene panel market and the reasons behind them? Q.7 What are some changing demands of customers in this gene panel market? Q.8 What are the new developments in this gene panel market? Which companies are leading these developments? Q.9 Who are the major players in this gene panel market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this gene panel market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global gene panel market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product & Service (Test Kits and Testing Services), Technique (Amplicon-based Approach and Hybridization-based Approach), Design (Predesigned Gene Panel and Customized Gene Panel), Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, and Other Applications), End User (Research and Academic Institutes, Hospital and Diagnostic Laboratories, and Pharmaceutical and Biotechnology Companies) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.